Search research articles
Contact Us
Filters
Showing results (61-70 of 79) with videos related to
Page
of 8
Sort By:
Translational Psychiatry
|
December 5, 2013
Latrepirdine: molecular mechanisms underlying potential therapeutic roles in Alzheimer's and other neurodegenerative diseases
P R Bharadwaj, K A Bates, T Porter, et al.
Neurology
|
September 4, 2008
Insulin in combination with other diabetes medication is associated with less Alzheimer neuropathology
M S Beeri, J Schmeidler, J M Silverman, et al.
Neuro-Oncology Advances
|
March 19, 2021
The promise of DNA damage response inhibitors for the treatment of glioblastoma
Nazanin K Majd, Timothy A Yap, Dimpy Koul, et al.
Neuroreport
|
December 29, 1995
High levels of amyloid-beta protein from S182 (Glu246) familial Alzheimer's cells
R N Martins, B A Turner, R T Carroll, et al.
Neuroscience
|
December 1, 1993
Regulated cleavage of Alzheimer beta-amyloid precursor protein in the absence of the cytoplasmic tail
O A da Cruz e Silva, K Iverfeldt, T Oltersdorf, et al.
Magnetic Resonance in Medicine
|
January 22, 2000
Diurnal variation in the femoral articular cartilage of the knee in young adult humans
J C Waterton, S Solloway, J E Foster, et al.
Molecular Medicine (Cambridge, Mass.)
|
September 29, 1999
Developmental expression of wild-type and mutant presenilin-1 in hippocampal neurons from transgenic mice: evidence for novel species-specific properties of human presenilin-1
L Lévesque, W Annaert, K Craessaerts, et al.
Molecular Psychiatry
|
March 3, 2004
Baculoviruses expressing the human familial Alzheimer's disease presenilin 1 mutation lacking exon 9 increase levels of an amyloid beta-like protein in Sf9 cells
G Verdile, D Groth, P M Mathews, et al.
Molecular Psychiatry
|
August 13, 2014
Proneurogenic Group II mGluR antagonist improves learning and reduces anxiety in Alzheimer Aβ oligomer mouse
S H Kim, J W Steele, S W Lee, et al.
Nature Medicine
|
July 1, 1997
Hyperaccumulation of FAD-linked presenilin 1 variants in vivo
M K Lee, D R Borchelt, G Kim, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 79) with videos related to
Sort By:
Page
of 8
Translational Psychiatry
|
December 5, 2013
Latrepirdine: molecular mechanisms underlying potential therapeutic roles in Alzheimer's and other neurodegenerative diseases
P R Bharadwaj, K A Bates, T Porter, et al.
Neurology
|
September 4, 2008
Insulin in combination with other diabetes medication is associated with less Alzheimer neuropathology
M S Beeri, J Schmeidler, J M Silverman, et al.
Neuro-Oncology Advances
|
March 19, 2021
The promise of DNA damage response inhibitors for the treatment of glioblastoma
Nazanin K Majd, Timothy A Yap, Dimpy Koul, et al.
Neuroreport
|
December 29, 1995
High levels of amyloid-beta protein from S182 (Glu246) familial Alzheimer's cells
R N Martins, B A Turner, R T Carroll, et al.
Neuroscience
|
December 1, 1993
Regulated cleavage of Alzheimer beta-amyloid precursor protein in the absence of the cytoplasmic tail
O A da Cruz e Silva, K Iverfeldt, T Oltersdorf, et al.
Magnetic Resonance in Medicine
|
January 22, 2000
Diurnal variation in the femoral articular cartilage of the knee in young adult humans
J C Waterton, S Solloway, J E Foster, et al.
Molecular Medicine (Cambridge, Mass.)
|
September 29, 1999
Developmental expression of wild-type and mutant presenilin-1 in hippocampal neurons from transgenic mice: evidence for novel species-specific properties of human presenilin-1
L Lévesque, W Annaert, K Craessaerts, et al.
Molecular Psychiatry
|
March 3, 2004
Baculoviruses expressing the human familial Alzheimer's disease presenilin 1 mutation lacking exon 9 increase levels of an amyloid beta-like protein in Sf9 cells
G Verdile, D Groth, P M Mathews, et al.
Molecular Psychiatry
|
August 13, 2014
Proneurogenic Group II mGluR antagonist improves learning and reduces anxiety in Alzheimer Aβ oligomer mouse
S H Kim, J W Steele, S W Lee, et al.
Nature Medicine
|
July 1, 1997
Hyperaccumulation of FAD-linked presenilin 1 variants in vivo
M K Lee, D R Borchelt, G Kim, et al.
Page
of 8